Comment: Inhaled Epoprostenol Through Noninvasive Routes of Ventilator Support Systems

Abstract

Get full access to this article

View all access options for this article.

References

Ammar

Sasidhar

Lam

SW.

Inhaled epoprostenol through noninvasive routes of ventilator support systems. Ann Pharmacother. 2018;52:1173-1181. doi:10.1177/1060028018782209

Zhu

Yin

Zhang

Wei

High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients with acute respiratory failure: a systematic review and meta-analysis of randomized controlled trials. BMC Pulm Med. 2017;17:201. doi:10.1186/s12890-017-0525-0

Réminiac

Vecellio

Heuzé-Vourc’h

et al . Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy. J Aerosol Med Pulm Drug Deliv. 2016;29:134-141. doi:10.1089/jamp.2015.1219

Alcoforado

Ari

De Melo Barcelar

Brandão

SCS

Fink

De Andrade

AD.

Deposition of aerosol via high flow nasal cannula is impacted by gas flow and heated humidity in vivo and in vitro. Am J Respir Crit Care Med. 2017;195:A3683.

Rice

Wheeler

Bernard

Hayden

Schoenfeld

Ware

; National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132:410-417. doi:10.1378/chest.07-0617